Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 23, 1993 - Issue 1
29
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetics of nefiracetam and three metabolites in humans and stereoselective hydroxylation of its pyrrolidine ring

, &
Pages 61-70 | Received 18 Mar 1992, Accepted 07 Aug 1992, Published online: 22 Sep 2008

References

  • Aso Y., Yoshioka S., Shibazaki T., Uchiyama M. The kinetics of the racemization of oxazepam in aqueous solution. Chemical and Pharmaceutical Bulletin 1988; 36: 1834–1840
  • Betzing H., Biedermann J., Materne C., Neuser V. 1980, Pyrrolidin-2-on-1-ylacetic acid 2,6-dimethylanilide, process of preparation and pharmaceutical compositions containing them. DE 2924011
  • Caldwell J., Winter S. M., Hutt A. J. The pharmacological and toxicological significance of the stereochemistry of drug disposition. Xenobiotica 1988; 18: 59–70
  • Fujimaki Y., Hashimoto K., Sudo K., Tachizawa H. Biotransformation of a new pyrrolidinone cognition-enhancing agent: isolation and identification of metabolites in human urine. Xenobiotica 1990; 20: 1081–1094
  • Fujimaki Y., Sudo K., Hakusui H. Simultaneous determination of nefiracetam and its metabolites by high-performance liquid chromatography. Journal of Chromatography 1992a; 575: 261–268
  • Fujimaki Y., Sudo K., Hakusui H., Tachizawa H., Murasaki M. Single-and multiple-dose pharmacokinetics of nefiracetam, a new nootropic agent in healthy human subjects. Journal of Pharmacy and Pharmacology 1992b; 44: 750–754
  • Kawajiri S., Sakurai T., Ojima H., Hatanaka S., Yamasaki T., Kojima H., Akashi A. Effect of DM-9384, a new pyrrolidone derivative, on learning behavior and cerebral choline acetyltransferase activity in rats. Psychopharmacology 1988; 96: 306, Suppl., Abst. 32.02.24
  • Nabeshima T., Noda Y., Tohyama K., Itoh J., Kameyama T. Effects of DM-9384 in a model of amnesia based on animals with GABAergic neuronal dysfunction. European Journal of Pharmacology 1990a; 178: 143–149
  • Nabeshima T., Tohyama K., Kameyama T. Effects of DM-9384, a pyrrolidone derivative, on alcohol- and chlordiazepoxide-induced amnesia in mice. Pharmacology Biochemistry and Behavior 1990b; 36: 233–236
  • Nabeshima T., Tohyama K., Murase K., Ishihara S., Kameyama T., Yamasaki T., Hatanaka S., Kojima H. Effects of DM-9384, a cyclic derivative of GABA, on cycloheximide-induced amnesia and GABAergic and cholinergic neuronal dysfunction. Journal of Pharmacology and Experimental Therapeutics 1991; 257: 271–275
  • Sakurai T., Ojima H., Yamasaki T., Kojima H., Akashi A. Effects of N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl) acetamide on learning and memory in rats. Japan Journal of Pharmacology 1989; 50: 47–53
  • Sakurai T., Hatanaka S., Tanaka S., Yamasaki T., Kojima H., Akashi A. Protective effect of DM-9384, a novel pyrrolidone derivative, against experimental cerebral anoxia. Japan Journal of Pharmacology 1990; 54: 33–43
  • Sudo K., Hashimoto K., Fujimaki Y., Tachizawa H. Disposition and metabolism of DM-9384, a cyclic GABA derivative, in the rat, dog and monkey. Psychopharmacology 1988; 96, (Suppl.) 306, Abst. 32.02.25
  • Testa B., Trager W. F. Racemates versus enantiomers in drug development: dogmatism or pragmatism?. Chirality 1990; 2: 129–133
  • Yamaoka K., Nakagawa T., Uno T. Statistical moments in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics 1978; 6: 547–558
  • Yang S. K., Lu X. Racemization kinetics of enantiomeric oxazepams and stereoselective hydrolysis of enantiomeric oxazepam 3-acetates in rat liver microsomes and brain homogenate. Journal of Pharmaceutical Sciences 1989; 78: 789–795

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.